Common Medicines More>>
- Dry eye disease
- Painful spasm
- postmenopausal women
- Sequelae of cerebral infarction
Oncology More>>
- biliary tract cancer
- T-cell leukemia lymphoma
- renal cell carcinoma
- Cell tumor
Hematology More>>
- Thalassemia
- Hemophilia
- 血红蛋白尿
- Leukemia
Hepatology More>>
- Cholangiocarcinoma
- hepatitis
- Primary Biliary Cholangitis
- Cholestasis
- Medication Guidance
- Medication Q&A
- Popular Drugs
- New Drugs
- Links
- Guidelines for the use of Glasdegib tablets combined with low-dose cytarabine in the treatment of AML in the United States
- Chinese instruction manual for Glasdegib tablets: Usage and side effects of drugs for the treatment of acute myeloid leukemia
- Tasfigo Succinate Chinese Instructions: Detailed Explanation of Side Effects
- The mechanism of action and clinical application of a new generation of tyrosine kinase inhibitors, Tissotinib Succinate from Eisai, Japan
- Japanese Eisai Succinate Tasfigo Approved Indications, Dosage, and Special Population Medication Recommendations
- The mechanism of action and cardiovascular benefits of ATP citrate lyase inhibitor and Bepedonic acid from Otsuka Pharmaceutical in Japan
- Guidelines and precautions for the use of Nexletol by Otsuka Pharmaceutical in the treatment of hypercholesterolemia in Japan
- Betamethasone: an innovative oral cholesterol lowering therapy for statin intolerant patients
- Chinese instruction manual for Nexletol, a drug used by Otsuka Pharmaceuticals in the treatment of hypercholesterolemia in Japan: Usage and side effects
- AstraZeneca's version of Saphnelo has been approved for indications, dosage, and recommendations for use in special populations
- Guidelines for the use of AstraZeneca version of Saphnelo monoclonal antibody in the treatment of moderate to severe systemic lupus erythematosus
- AstraZeneca Annilumab: Innovative Therapy for Systemic Lupus Erythematosus Targeting Type I Interferon Receptors